Palonosetron Hydrochloride Injection, Solution
Product Images NDC 0703-4094

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Palonosetron Hydrochloride (NDC 0703-4094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Parenteral Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Palonosetron Hydrochloride Structural Formula (Palonosetron Injection A090713 1)

Chemical structure diagram of Palonosetron Hydrochloride, showing its molecular framework including a bicyclic ring system with attached nitrogen and hydrogen atoms, and the hydrochloride component (HCl).*

FDA Label Image

Table 4 Image (Palonosetron Injection A090713 2)

A data table presenting chemotherapy study results comparing Palonosetron Hydrochloride Injection 0.25 mg intravenously with other treatments in moderately and highly emetogenic chemotherapy. Columns detail treatment groups, number of subjects, percentage with complete response, p-values, and a confidence interval graph for response rate differences.*

FDA Label Image

Table 5 Image (Palonosetron Injection A090713 3)

A data table presenting study results on chemotherapy, treatment groups, response rates, and p-values comparing Palonosetron Hydrochloride Injection 0.25 mg intravenously against Ondansetron and Dolasetron in moderately emetogenic chemotherapy. Includes a confidence interval chart for difference in complete response rates between Palonosetron and comparator treatments.*

FDA Label Image

Table 6 Image (Palonosetron Injection A090713 4)

A data table presenting clinical study results comparing complete response rates of Palonosetron Hydrochloride Injection 0.25 mg intravenously against other treatments (Ondansetron 32 mg and Dolasetron 100 mg) in moderately emetogenic chemotherapy. It includes treatment groups, sample sizes, percentage with complete response, p-values, and a 97.5% confidence interval graph for difference in complete response rates between Palonosetron Hydrochloride and comparators.*

FDA Label Image

Table 8 Image (Palonosetron Injection A090713 5)

Label for Palonosetron HCl Injection, 0.25 mg/5 mL (0.05 mg/mL) single-dose sterile vial for intravenous injection. The label includes dosage instructions, storage conditions, manufacturer information (Teva Parenteral Medicines, Inc.), NDC 0703-4094-01, and a barcode. The design features a teal Teva logo strip at the bottom and key product details prominently displayed on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.